Buy or sell EGenesis stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

EGenesis Stock

EGenesis designs xenotransplantation for the benefit of human health.

Founded

2014

Headquarters

Cambridge MA, US

Total Funding

$140M

About EGenesis Stock

EGenesis designs xenotransplantation for the benefit of human health. Its technology helps transform xenotransplantation into a medical procedure, enabling clinical researchers to address the global organ shortage.

Funding History

August 2016$2.0M
March 2017$38.0M
November 2019$100M

Management

Chief Operating Officer

Kenneth Fan

Executive Vice President of Research and Development

William Westlin

Chief Scientific Officer

Luhan Yang

Chief Executive Officer

Paul Sekhri

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from EGenesis or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo